Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(40%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
20%
Ph not_applicable
2
40%
Ph phase_2
1
20%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Completed(1)
Other(1)

Detailed Status

Recruiting2
Not yet recruiting1
Completed1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (25.0%)
Phase 31 (25.0%)
N/A2 (50.0%)

Trials by Status

not_yet_recruiting120%
completed120%
recruiting240%
unknown120%

Recent Activity

2 active trials
Showing 5 of 5
recruitingnot_applicable

Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion

NCT07185022
not_yet_recruitingphase_3

Efficacy and Safety of Intra-arterial Tenecteplase in Acute Ischemic Stroke Patients With Medium Vessel Occlusion Stroke (DATE-MeVO)

NCT07469293
recruitingphase_2

Intra-arterial Recombinant Human Tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Medium Vessel Occlusion

NCT07302854
unknownnot_applicable

Safety and Efficacy After Selective Intra-arterial Thrombolysis for Central Retinal Artery Occlusion

NCT05562284
completed

Swiss Intravenous and Intra-arterial Thrombolysis for Treatment of Acute Ischemic Stroke Registry

NCT00811538

Clinical Trials (5)

Showing 5 of 5 trials
NCT07185022Not Applicable

Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion

Recruiting
NCT07469293Phase 3

Efficacy and Safety of Intra-arterial Tenecteplase in Acute Ischemic Stroke Patients With Medium Vessel Occlusion Stroke (DATE-MeVO)

Not Yet Recruiting
NCT07302854Phase 2

Intra-arterial Recombinant Human Tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Medium Vessel Occlusion

Recruiting
NCT05562284Not Applicable

Safety and Efficacy After Selective Intra-arterial Thrombolysis for Central Retinal Artery Occlusion

Unknown
NCT00811538

Swiss Intravenous and Intra-arterial Thrombolysis for Treatment of Acute Ischemic Stroke Registry

Completed

All 5 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
5